We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+29.06%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$635M
AUM Growth
-$118M
Cap. Flow
-$205M
Cap. Flow %
-32.24%
Top 10 Hldgs %
8.47%
Holding
431
New
122
Increased
24
Reduced
159
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 22.07%
2 Healthcare 21.95%
3 Industrials 15.49%
4 Financials 10.29%
5 Consumer Discretionary 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKAO
1
DELISTED
Achaogen Inc
AKAO
$7M 1.1%
277,567
-155,148
-36% -$3.19M
UCTT
2
Ultra Clean Holdings
UCTT
$4.32B
$6.28M 0.99%
372,257
+92,538
+33% +$1.23M
HSKA
3
DELISTED
Heska Corp
HSKA
$5.43M 0.86%
51,757
-49,684
-49% -$4.25M
OSUR icon
4
OraSure Technologies
OSUR
$281M
$5.32M 0.84%
411,674
+69,678
+20% +$721K
AAOI icon
5
Applied Optoelectronics
AAOI
$8.28B
$5.32M 0.84%
94,764
-34,264
-27% -$1.35M
TRUE
6
DELISTED
TrueCar
TRUE
$5.06M 0.8%
327,349
+10,996
+3% +$153K
BEAT
7
DELISTED
BioTelemetry, Inc.
BEAT
$5.04M 0.79%
174,092
-17,582
-9% -$436K
EXEL icon
8
Exelixis
EXEL
$14B
$4.84M 0.76%
223,370
+45,895
+26% +$933K
ONTO icon
9
Onto Innovation
ONTO
$13.9B
$4.83M 0.76%
158,545
-1,834
-1% -$49.7K
LUMO
10
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$4.62M 0.73%
+21,311
New +$3.04M
TDOC icon
11
Teladoc Health
TDOC
$1.61B
$4.58M 0.72%
+183,360
New +$3.81M
ESPR
12
DELISTED
Esperion Therapeutics
ESPR
$4.53M 0.71%
+128,300
New +$2.94M
EXTR icon
13
Extreme Networks
EXTR
$3.88B
$4.41M 0.7%
+587,508
New +$3.52M
NTRI
14
DELISTED
NutriSystem, Inc.
NTRI
$4.4M 0.69%
79,268
-39,667
-33% -$1.64M
LOXO
15
DELISTED
Loxo Oncology, Inc
LOXO
$4.34M 0.68%
103,149
-8,119
-7% -$334K
AERI
16
DELISTED
Aerie Pharmaceuticals
AERI
$4.22M 0.66%
92,963
-7,796
-8% -$348K
TVTY
17
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$4.17M 0.66%
+143,429
New +$3.78M
AQMS icon
18
Aqua Metals
AQMS
$9.7M
$4.15M 0.65%
1,063
+559
+111% +$1.74M
TVRD
19
Tvardi Therapeutics
TVRD
$23.5M
$4.13M 0.65%
6,246
-413
-6% -$221K
XPO icon
20
XPO
XPO
$25.2B
$4.13M 0.65%
249,588
-16,579
-6% -$271K
GOGL
21
DELISTED
Golden Ocean Group
GOGL
$4.08M 0.64%
+536,521
New +$3.36M
AZTA icon
22
Azenta
AZTA
$1.27B
$4.06M 0.64%
181,175
+115,429
+176% +$2.29M
KTOS icon
23
Kratos Defense & Security Solutions
KTOS
$8.98B
$4.04M 0.64%
519,204
-339,425
-40% -$2.71M
COHR
24
DELISTED
Coherent Inc
COHR
$3.99M 0.63%
19,395
-5,072
-21% -$887K
CGNX icon
25
Cognex
CGNX
$10.5B
$3.93M 0.62%
93,626
-6,144
-6% -$225K

Similar funds

EAM Investors's Q1 2017 Portfolio in Review

As of Q1 2017, EAM Investors held 431 positions worth $635M, down 16% from $752M the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

EAM Investors withdrew a net $205M in Q1 2017, closing 124 positions and reducing 159 holdings. Its most notable exit was Horizon Global Corporation, an estimated $7.38M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, EAM Investors opened a new position in Teladoc Health worth $4.58M.

  • EAM Investors's largest Q1 2017 buy was Teladoc Health: 183,360 shares worth $4.58M.
  • EAM Investors added most to Azenta in Q1 2017, an estimated $2.29M increase.
  • EAM Investors's biggest Q1 2017 reduction was Hudson Technologies, cutting an estimated $4.57M.
  • EAM Investors fully exited Horizon Global Corporation in Q1 2017, selling an estimated $7.38M.
  • EAM Investors's ten largest holdings make up 8.5% of its $635M portfolio in Q1 2017.
  • EAM Investors opened 122 new positions and closed 124 in Q1 2017.
  • EAM Investors's portfolio value fell 16% quarter-over-quarter to $635M.

Based on EAM Investors's 13F filing for Q1 2017, filed 10 May 2017.